nasus-post

Nasus pharma Announces Launch of TaffiX ™ – a personal “anti-virus” product in Israel.bio

Tel Aviv, July 2nd 2020. 

Tel Aviv based Nasus Pharma ( https://www.nasuspharma.com/ ) a biopharma company focused on intranasal drug delivery is pleased to announce the launch in Israel of TaffiX – a “personal anti-virus” nasal powder spray indicated for blocking viruses in the nasal cavity .  

The marketing, sales & distribution partner for the Israeli market is CTS LTD – one of the largest and well-established pharma companies in Israel.  

TaffiX is approved by Israel Ministry of Health  as a Medical Device, and is sold in pharmacies and pharmacy chains in Israel

For further information please use the following links:http://www.TaffiX.co.il and https://www.nasuspharma.com/taffix/

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email